Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 7801–7850 of 33113
It is with great sadness that J.B. Hunt Transport Services, Inc. (the “Company”) announces that Patrick Ottensmeyer passed away on July 28, 2024.
Timothy Moran, Scott Durbin, Sonja Nelson, Mark Pomeranz and Gary Pruden resigned from the Board of Directors
Timothy Moran, Scott Durbin, Sonja Nelson, Mark Pomeranz and Gary Pruden resigned from the Board of Directors
Timothy Moran, Scott Durbin, Sonja Nelson, Mark Pomeranz and Gary Pruden resigned from the Board of Directors
Additionally, Mark Pomeranz resigned from his role as Chief Executive Officer of the Company.
Timothy Moran, Scott Durbin, Sonja Nelson, Mark Pomeranz and Gary Pruden resigned from the Board of Directors
Timothy Moran, Scott Durbin, Sonja Nelson, Mark Pomeranz and Gary Pruden resigned from the Board of Directors
Irwin Golds, Kaveh Varjavand and Anita Wolman (the “Retiring Directors”) retired from the SCB Board effective at the Effective Time.
Irwin Golds, Kaveh Varjavand and Anita Wolman (the “Retiring Directors”) retired from the SCB Board effective at the Effective Time.
Irwin Golds, Kaveh Varjavand and Anita Wolman (the “Retiring Directors”) retired from the SCB Board effective at the Effective Time.
Effective upon the closing of the Business Combination, each of Chung-Yi Sun, Cheng-Nan Wu, Lin Bao, Jung-Te Chang and Grace F. L. Peng ceased serving as a director of the Company, and each of Chung-Yi Sun and Cheng-Nan Wu ceased serving as an executive officer of the Company.
Effective upon the closing of the Business Combination, each of Chung-Yi Sun, Cheng-Nan Wu, Lin Bao, Jung-Te Chang and Grace F. L. Peng ceased serving as a director of the Company, and each of Chung-Yi Sun and Cheng-Nan Wu ceased serving as an executive officer of the Company.
Effective upon the closing of the Business Combination, each of Chung-Yi Sun, Cheng-Nan Wu, Lin Bao, Jung-Te Chang and Grace F. L. Peng ceased serving as a director of the Company, and each of Chung-Yi Sun and Cheng-Nan Wu ceased serving as an executive officer of the Company.
Effective upon the closing of the Business Combination, each of Chung-Yi Sun, Cheng-Nan Wu, Lin Bao, Jung-Te Chang and Grace F. L. Peng ceased serving as a director of the Company, and each of Chung-Yi Sun and Cheng-Nan Wu ceased serving as an executive officer of the Company.
Effective upon the closing of the Business Combination, each of Chung-Yi Sun, Cheng-Nan Wu, Lin Bao, Jung-Te Chang and Grace F. L. Peng ceased serving as a director of the Company, and each of Chung-Yi Sun and Cheng-Nan Wu ceased serving as an executive officer of the Company.
Effective upon the closing of the Business Combination, each of Chung-Yi Sun, Cheng-Nan Wu, Lin Bao, Jung-Te Chang and Grace F. L. Peng ceased serving as a director of the Company, and each of Chung-Yi Sun and Cheng-Nan Wu ceased serving as an executive officer of the Company.
Effective upon the closing of the Business Combination, each of Chung-Yi Sun, Cheng-Nan Wu, Lin Bao, Jung-Te Chang and Grace F. L. Peng ceased serving as a director of the Company, and each of Chung-Yi Sun and Cheng-Nan Wu ceased serving as an executive officer of the Company.
On July 29, 2024, Shimon Rapp and Andrew Sycoff resigned from the board of directors.
On July 29, 2024, Shimon Rapp and Andrew Sycoff resigned from the board of directors.
On July 26, 2024, Bradley (“Brad”) Weston provided notice of his decision to resign from the Board of Directors (the “Board”) of Vera Bradley, Inc. (the “Company”) effective August 30, 2024.
On July 30, 2024, Joel V. Staff notified Kinder Morgan, Inc. (“KMI”) that he will retire from KMI’s Board of Directors effective August 1, 2024.
On July 25, 2024, the Company received written notice from Solomon Adote of his resignation as a member of the Board of Directors
On July 25, 2024, the Company received written notice from Dr. Emmanuel Esaka of his resignation as a member of the Board of Directors
David J. Anderson, executive vice president and chief financial officer, notified the Company on July 26, 2024, of his intent to retire effective September 16, 2024.
Peter M. Fasolo, Ph.D., and Joseph J. Wolk each informed Kenvue Inc. (the "Company") and its Board of Directors (the "Board") of their decision to resign from the Board, effective as of December 1, 2024.
Peter M. Fasolo, Ph.D., and Joseph J. Wolk each informed Kenvue Inc. (the "Company") and its Board of Directors (the "Board") of their decision to resign from the Board, effective as of December 1, 2024.
On July 29, 2024, Patrick Roney notified the Board of his decision to resign from his position as Executive Chairman of the Board, effective August 1, 2024.
On July 24, 2024, Carrie Lazorchak, the Chief Revenue Officer of the Company, provided the Company with notice of her resignation, effective August 2, 2024.
On July 30, 2024, in connection with the planned wind down of the Company’s operations, Charles P. Theuer, M.D., Ph.D., Lisa Johnson-Pratt, M.D., Carol C. Lam. J.D., William R. LaRue, Martin A. Mattingly, Pharm.D., Saundra Pelletier, J. Rainer Twiford, J.D., Ph.D. and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the Board and all committees thereof, effective July 31, 2024.
In connection with the Reduction in Force, Scott B. Brown, CPA, Chief Financial Officer and Secretary will cease serving as an officer of the Company effective July 31, 2024.
On July 30, 2024, in connection with the planned wind down of the Company’s operations, Charles P. Theuer, M.D., Ph.D., Lisa Johnson-Pratt, M.D., Carol C. Lam. J.D., William R. LaRue, Martin A. Mattingly, Pharm.D., Saundra Pelletier, J. Rainer Twiford, J.D., Ph.D. and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the Board and all committees thereof, effective July 31, 2024.
On July 30, 2024, in connection with the planned wind down of the Company’s operations, Charles P. Theuer, M.D., Ph.D., Lisa Johnson-Pratt, M.D., Carol C. Lam. J.D., William R. LaRue, Martin A. Mattingly, Pharm.D., Saundra Pelletier, J. Rainer Twiford, J.D., Ph.D. and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the Board and all committees thereof, effective July 31, 2024.
On July 30, 2024, in connection with the planned wind down of the Company’s operations, Charles P. Theuer, M.D., Ph.D., Lisa Johnson-Pratt, M.D., Carol C. Lam. J.D., William R. LaRue, Martin A. Mattingly, Pharm.D., Saundra Pelletier, J. Rainer Twiford, J.D., Ph.D. and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the Board and all committees thereof, effective July 31, 2024.
On July 30, 2024, in connection with the planned wind down of the Company’s operations, Charles P. Theuer, M.D., Ph.D., Lisa Johnson-Pratt, M.D., Carol C. Lam. J.D., William R. LaRue, Martin A. Mattingly, Pharm.D., Saundra Pelletier, J. Rainer Twiford, J.D., Ph.D. and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the Board and all committees thereof, effective July 31, 2024.
On July 30, 2024, in connection with the planned wind down of the Company’s operations, Charles P. Theuer, M.D., Ph.D., Lisa Johnson-Pratt, M.D., Carol C. Lam. J.D., William R. LaRue, Martin A. Mattingly, Pharm.D., Saundra Pelletier, J. Rainer Twiford, J.D., Ph.D. and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the Board and all committees thereof, effective July 31, 2024.
On July 30, 2024, in connection with the planned wind down of the Company’s operations, Charles P. Theuer, M.D., Ph.D., Lisa Johnson-Pratt, M.D., Carol C. Lam. J.D., William R. LaRue, Martin A. Mattingly, Pharm.D., Saundra Pelletier, J. Rainer Twiford, J.D., Ph.D. and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the Board and all committees thereof, effective July 31, 2024.
On July 30, 2024, Charles P. Theuer, M.D., Ph.D., tendered his resignation as the Company’s President and Chief Executive Officer, to be effective as of July 31, 2024.
On July 30, 2024, in connection with the planned wind down of the Company’s operations, Charles P. Theuer, M.D., Ph.D., Lisa Johnson-Pratt, M.D., Carol C. Lam. J.D., William R. LaRue, Martin A. Mattingly, Pharm.D., Saundra Pelletier, J. Rainer Twiford, J.D., Ph.D. and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the Board and all committees thereof, effective July 31, 2024.
On July 30, 2024, Michael J. Burbach, age 63, notified the Company of his intent to retire from his position as our Chief Operating Officer, effective December 31, 2024.
the following officers of PERAC resigned from their respective positions: David Roberts (Chief Operating Officer), Tim Dummer (Head of Business Strategy) and Kathy Liu (Head of Technology Strategy)
each of Michael Browning (Chairman of the Board), Eric Spiegel and Nina Jensen ceased to be a director of PERAC
each of Michael Browning (Chairman of the Board), Eric Spiegel and Nina Jensen ceased to be a director of PERAC
each of Michael Browning (Chairman of the Board), Eric Spiegel and Nina Jensen ceased to be a director of PERAC
the following officers of PERAC resigned from their respective positions: David Roberts (Chief Operating Officer), Tim Dummer (Head of Business Strategy) and Kathy Liu (Head of Technology Strategy)
the following officers of PERAC resigned from their respective positions: David Roberts (Chief Operating Officer), Tim Dummer (Head of Business Strategy) and Kathy Liu (Head of Technology Strategy)
On July 26, 2024, Frank Pelzer, Executive Vice President and Chief Financial Officer of F5, Inc. (the “Company”), informed the Company of his plans to retire during the Company’s first fiscal quarter 2025, which ends December 31, 2024.
Stephen Goodman ceased to act as a director of the Company on July 26, 2024.
On July 26, 2024, Donald B. Murray notified Resources Connection, Inc. (the “Company”) of his resignation from his position as the Chairman and a member of the Board of Directors (the “Board”) of the Company.
Christopher S. Sotos informed Clearway Energy, Inc. (“ Clearway, Inc. ”), the parent company of the Company, on April 30, 2024 that, effective as of June 30, 2024, he will move on from his position as President and Chief Executive Officer of Clearway, Inc. and the Company.
Simultaneously, on such date, Nat Krishnamurti stepped down, effective immediately, from his positions as Vice President, Chief Financial Officer and Secretary of the Company.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.